Cargando…

Urine-derived cells for human cell therapy

Desirable cells for human cell therapy would be ones that can be generated by simple isolation and culture techniques using a donor sample obtained by non-invasive methods. To date, the different donor-specific cells that can be isolated from blood, skin, and hair require invasive methods for sample...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavathuparambil Abdul Manaph, Nimshitha, Al-Hawaas, Mohammed, Bobrovskaya, Larisa, Coates, Patrick T., Zhou, Xin-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042455/
https://www.ncbi.nlm.nih.gov/pubmed/29996911
http://dx.doi.org/10.1186/s13287-018-0932-z
_version_ 1783339158009282560
author Pavathuparambil Abdul Manaph, Nimshitha
Al-Hawaas, Mohammed
Bobrovskaya, Larisa
Coates, Patrick T.
Zhou, Xin-Fu
author_facet Pavathuparambil Abdul Manaph, Nimshitha
Al-Hawaas, Mohammed
Bobrovskaya, Larisa
Coates, Patrick T.
Zhou, Xin-Fu
author_sort Pavathuparambil Abdul Manaph, Nimshitha
collection PubMed
description Desirable cells for human cell therapy would be ones that can be generated by simple isolation and culture techniques using a donor sample obtained by non-invasive methods. To date, the different donor-specific cells that can be isolated from blood, skin, and hair require invasive methods for sample isolation and incorporate complex and costly reagents to culture. These cells also take considerable time for their in-vitro isolation and expansion. Previous studies suggest that donor-derived cells, namely urine stem cells and renal cells, may be isolated from human urine samples using a cost-effective and simple method of isolation, incorporating not such complex reagents. Moreover, the isolated cells, particularly urine stem cells, are superior to conventional stem cell sources in terms of favourable gene profile and inherent multipotent potential. Transdifferentiation or differentiation of human urine-derived cells can generate desirable cells for regenerative therapy. In this review, we intended to discuss the characteristics and therapeutic applications of urine-derived cells for human cell therapy. Conclusively, with detailed study and optimisation, urine-derived cells have a prospective future to generate functional lineage-specific cells for patients from a clinical translation point of view.
format Online
Article
Text
id pubmed-6042455
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60424552018-07-13 Urine-derived cells for human cell therapy Pavathuparambil Abdul Manaph, Nimshitha Al-Hawaas, Mohammed Bobrovskaya, Larisa Coates, Patrick T. Zhou, Xin-Fu Stem Cell Res Ther Review Desirable cells for human cell therapy would be ones that can be generated by simple isolation and culture techniques using a donor sample obtained by non-invasive methods. To date, the different donor-specific cells that can be isolated from blood, skin, and hair require invasive methods for sample isolation and incorporate complex and costly reagents to culture. These cells also take considerable time for their in-vitro isolation and expansion. Previous studies suggest that donor-derived cells, namely urine stem cells and renal cells, may be isolated from human urine samples using a cost-effective and simple method of isolation, incorporating not such complex reagents. Moreover, the isolated cells, particularly urine stem cells, are superior to conventional stem cell sources in terms of favourable gene profile and inherent multipotent potential. Transdifferentiation or differentiation of human urine-derived cells can generate desirable cells for regenerative therapy. In this review, we intended to discuss the characteristics and therapeutic applications of urine-derived cells for human cell therapy. Conclusively, with detailed study and optimisation, urine-derived cells have a prospective future to generate functional lineage-specific cells for patients from a clinical translation point of view. BioMed Central 2018-07-11 /pmc/articles/PMC6042455/ /pubmed/29996911 http://dx.doi.org/10.1186/s13287-018-0932-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Pavathuparambil Abdul Manaph, Nimshitha
Al-Hawaas, Mohammed
Bobrovskaya, Larisa
Coates, Patrick T.
Zhou, Xin-Fu
Urine-derived cells for human cell therapy
title Urine-derived cells for human cell therapy
title_full Urine-derived cells for human cell therapy
title_fullStr Urine-derived cells for human cell therapy
title_full_unstemmed Urine-derived cells for human cell therapy
title_short Urine-derived cells for human cell therapy
title_sort urine-derived cells for human cell therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042455/
https://www.ncbi.nlm.nih.gov/pubmed/29996911
http://dx.doi.org/10.1186/s13287-018-0932-z
work_keys_str_mv AT pavathuparambilabdulmanaphnimshitha urinederivedcellsforhumancelltherapy
AT alhawaasmohammed urinederivedcellsforhumancelltherapy
AT bobrovskayalarisa urinederivedcellsforhumancelltherapy
AT coatespatrickt urinederivedcellsforhumancelltherapy
AT zhouxinfu urinederivedcellsforhumancelltherapy